Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MEG9 - MicroRNA-135b overexpression effect on prostate cancer cell line: time course
GEO DataSets Gene Profile neighbors Chromosome neighbors
MEG9 - Sendai virus infection effect on monocytic cell line: dose response
GEO DataSets Gene Chromosome neighbors
MEG9 - Influenza A effect on plasmacytoid dendritic cells
MEG9 - Metastatic breast cancer and sepsis: monocytes
MEG9 - Methyltransferase EZH2 inhibition effect on ARID1A mutated ovarian clear cell cancer cell line
MEG9 - Protein kinase C δ deficiency effect on breast cancer cells
MEG9 - Interstitial fluid flow effect on noninvasive and invasive ERBB2-positive breast cancer cells
MEG9 - ErbB4 isoforms CYT-1 and CYT-2 overexpression effect on MCF10A mammary epithelial cells
MEG9 - Histone demethylase KDM3A-deficiency effect on estrogen-stimulated breast cancer cells in vitro
MEG9 - Bladder cancer extracellular vesicles
MEG9 - Early Parkinson's disease: peripheral blood
MEG9 - Epithelial stem cells derived from induced pluripotent stem cells
MEG9 - Dasatinib-resistant and dasatinib-sensitive pancreatic cancer cell lines
MEG9 - pH1N1 influenza virus infection of interferon regulatory factor 7-deficient peripheral blood mononuclear cells: time course
MEG9 - Myelodysplastic syndrome disorder: bone marrow mesenchymal stromal cells
MEG9 - Estradiol effect on MCF7 breast cancer cells expressing progesterone receptor-B
MEG9 - H3K79 histone methyl transferase DOT1L inhibitor Compound 55 effect on breast cancer cells: dose response
MEG9 - H3K79 histone methyl transferase DOT1L inhibitor EPZ004777 effect on breast cancer cells: dose response
MEG9 - Oral histone deacetylase inhibitor ST7612AA1 effect on diffuse large B-cell lymphoma in vitro models
MEG9 - Ventricular cardiomyocytes generated in vitro from embryonic stem cells
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on